human aml cell line u937 (ATCC)
Structured Review
Human Aml Cell Line U937, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 6905 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aml+cell+lines/U-937/pmc13000501-55-1-10
Average 99 stars, based on 6905 article reviews
Images
Related Articles
Cell Culture:Article Title: PTBP1 Facilitates Acute Myeloid Leukemia Cell Migration, Invasion, and Expression of EMT Markers by Regulating WNK1 Article Snippet: .. Normal human bone marrow stromal cell line HS-5 and Article Title: Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia. Article Snippet: .. In vitro and ex vivo cell culture and myeloid differentiation: other:Article Title: Co-Expression of IL-2 Enhances the Efficacy of FLT3-CAR-γδT Cells in Acute Myeloid Leukemia. Article Snippet: The Article Title: Co-Expression of IL-2 Enhances the Efficacy of FLT3-CAR-γδT Cells in Acute Myeloid Leukemia Article Snippet: The In Vitro:Article Title: Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia. Article Snippet: .. In vitro and ex vivo cell culture and myeloid differentiation: Ex Vivo:Article Title: Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia. Article Snippet: .. In vitro and ex vivo cell culture and myeloid differentiation: |
![Expression of ALDH3A2 in healthy people and patients with AML (A) The expression of ALDH3A2 in various tumors compared with normal tissues. Data are represented as mean ± SEM. (B) Expression of ALDH3A2 in 88 leukemia cell lines. (C) The survival curve of patients with high and low expression of ALDH3A2 (n [low expression] = 121, n [high expression] = 30). (D) The expression of protein ALDH3A2 in <t>HL-60,</t> HL-60/ADM, K562, K562/ADM, and bone marrow in patients. (E) The expression of ALDH3A2 RNA in bone marrow mononuclear cells of AML patients in the CR ( n = 9), C1NR ( n = 8), and R/R ( n = 10) group. Data are represented as mean ± SEM. (F) The expression of ALDH3A2 in bone marrow mononuclear cells of 3 AML patients at their initial and recurrent stage. (G) High/low expression of ALDH3A2 and molecular mutation distribution of 66 AML patients. Data are represented as mean ± SEM. Ns indicates no statistical difference between the two groups, ∗ indicates p < 0.05 between the two groups. Statistical significance was determined using unpaired two-tailed Student’s t tests for the comparison of two groups.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4865/pmc13254865/pmc13254865__gr1.jpg)